Drug Pricing in Saudi Arabia

Panel

Panel 10: An International Perspective

Moderator

Mark Christiansen, Associate Clinical Professor, University of the Pacific, Physician Assistant Program

Description

Medicines are free of charge to all citizens in the Kingdom of Saudi Arabia through public health care facilities. However, due to the high demand on public health care facilities, many citizens utilize private health care facilities where they pay out of their pockets. Based on that, the medicine market in the Kingdom rose to reach approximately US $ 5.30 billion and pharmaceutical manufacturing within the Kingdom will reach 40% by 2020. The Kingdom has taken many steps to keep prices fair and medicines accessible to all citizens. I will go over the most important steps that the Kingdom has taken to manage prices.

Speaker Bio

Aziz Alkhalifa is a Lecturer of Law at Prince Sattam University. He earned his LL.M. from University of California, Davis, King Hall School of Law where he studied intellectual property law. He was born and raised in Riyadh, Saudi Arabia.

He has developed a passion for intellectual property law and its relationship with free speech. He is currently a J.S.D. candidate at University of the Pacific, McGeorge School of Law. His research focuses on the development of copyright and trademark law, and its impact on free speech in Saudi Arabia.

Location

Pacific McGeorge School of Law, Lecture Hall, 3200 Fifth Ave., Sacramento, CA

This document is currently not available here.

Share

COinS
 
Apr 6th, 11:00 AM Apr 6th, 12:00 PM

Drug Pricing in Saudi Arabia

Pacific McGeorge School of Law, Lecture Hall, 3200 Fifth Ave., Sacramento, CA

Medicines are free of charge to all citizens in the Kingdom of Saudi Arabia through public health care facilities. However, due to the high demand on public health care facilities, many citizens utilize private health care facilities where they pay out of their pockets. Based on that, the medicine market in the Kingdom rose to reach approximately US $ 5.30 billion and pharmaceutical manufacturing within the Kingdom will reach 40% by 2020. The Kingdom has taken many steps to keep prices fair and medicines accessible to all citizens. I will go over the most important steps that the Kingdom has taken to manage prices.